PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-21.22%
Both yoy net incomes decline, with MRVL at -34.10%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
2.96%
D&A growth well above MRVL's 0.46%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
440.14%
Some yoy growth while MRVL is negative at -100.03%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
25.11%
SBC growth while MRVL is negative at -12.15%. John Neff would see competitor possibly controlling share issuance more tightly.
-118.55%
Negative yoy working capital usage while MRVL is 20.98%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-88.57%
AR is negative yoy while MRVL is 296.06%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-207.86%
Both reduce yoy inventory, with MRVL at -210.20%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
212.15%
AP growth well above MRVL's 75.34%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-136.03%
Negative yoy usage while MRVL is 24.70%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
40.14%
Lower 'other non-cash' growth vs. MRVL's 273.84%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-60.38%
Both yoy CFO lines are negative, with MRVL at -29.38%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-46.16%
Negative yoy CapEx while MRVL is 45.70%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
18.71%
Some yoy expansion while MRVL is negative at -181.93%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-13.40%
We reduce yoy sales while MRVL is 36.81%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
24.46%
Growth of 24.46% while MRVL is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
18.35%
We have mild expansions while MRVL is negative at -404.74%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
59.77%
We repay more while MRVL is negative at -2.20%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
16.60%
We slightly raise equity while MRVL is negative at -92.37%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.